Back to results
US 5,473,099 AGranted
Ethyl 4-trichloroacetamido-4-hexenoate
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorPatrick Casara
Life of this patent
Estimating the term…
Abstract
This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
Claims1
[4]Ethyl-4-trichloroacetamido-4-hexenoate.
Dependencies are inferred from the claim text.